[Advantages and hazards of drug treatment in surgery. Anticoagulants and fibrinolytic agents].
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000502:physiology; D003374:Coumarins / Q000009:adverse effects / Q000627:therapeutic use; D005342:Fibrinolysis / Q000502:physiology; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007192:Indenes / Q000009:adverse effects / Q000627:therapeutic use; D008134:Long-Term Care; D009203:Myocardial Infarction / Q000188:drug therapy; D011655:Pulmonary Embolism / Q000188:drug therapy; D013300:Streptokinase / Q000009:adverse effects / Q000627:therapeutic use; D013514:Surgical Procedures, Operative; D013923:Thromboembolism / Q000188:drug therapy
D000925:Anticoagulants; D003374:Coumarins; D005343:Fibrinolytic Agents; D007192:Indenes; D006493:Heparin; D013300:Streptokinase
Nutzen und Gefahren medikamentöser Behandlung in der Chirurgie. Anticoagulantien und Fibrinolytica.